MedPath

Comparison of dualL-Trigger and hcg-Trigger on infertile patients with normal ovarian response

Not Applicable
Conditions
infertility.
N97.0,N97.
Female infertility associated with anovulation,Female infertility of tubal origin,Female infertility associated with male factors,Female infertility of other origin,Female infertility, unspecified,
Registration Number
IRCT2015061722795N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
126
Inclusion Criteria

inclusion criteria:
age18-40 years;regular mense(25-34 days);BMI between 18-35;FSH days 3 <10
exclusion criteria:
FSH days 3 >=10;AMH=<1.1;expectancy for ovarian hyper response(>=16 follicles on the last trans vaginal sonography );endocrine deases(DM ,hyperprolactinemia,thyroide dysfunction ,CAH,cushing syndrome);PCOs;uterine anomaly in HSG or hysteroscopy;sever male factor(azospermia require to TESE or PESA);history of OHSS;criteria of ovarian hyper response or ovarian poor response

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of Metaphase II oocyte. Timepoint: on oocyte retrieval day. Method of measurement: evaluation by embryologist under microscope.;Number of Metaphase II oocytse ,total number of oocytes,number of embryoss. Timepoint: oocyte retrieval day,day3 after oocyte retrieval or IVF. Method of measurement: evaluation under microscope by an embryologist and scoring by scientific evidence.
Secondary Outcome Measures
NameTimeMethod
Biochemical pregnancy ,clinical pregnancy,abortion ,OHSS. Timepoint: two weeks after transfer for biochemical pregnancy,4weeks for clinical pregnancy,2 weeks after transfer for OHSS. Method of measurement: BHCG for biochemical ,trans vaginal sonography for clinical,clinical evaluation for OHSS.
© Copyright 2025. All Rights Reserved by MedPath